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Objective: To describe the application of a new, objective diagnostic test for Meniere? s disease.
Introduction: Electrovestibulography (EVestG) is a complex, newly-developed test paradigm that searches for neural
firing patterns that may be diagnostic for particular neural disorders. EVestG system was previously ? trained ? to
distinguish Meniere ? s disease from other patients on a set of training data. In this paper we illustrate its diagnostic
application in a new group of unknown subjects.
Setting: Collaborative Academic Bioengineering Research Centre.
Study design: Prospective, blinded human Clinical Trial.
Methods: In an attempt to understand the specific neural firing patterns that may objectively characterize latent
Meniere ? s disease, two hundred fifty-six consecutive patients who presented for electronystagmography testing
were asked to undergo EVestG testing. Ten subjects actually completed testing but data were too noisy to permit
analysis for one patient. Complete data were available for nine patients with either a clinical diagnosis of either
Meniere ? s disease (4 patients) or some other vestibular disorder (2 vestibular neuritis, 2 benign positional vertigo
and 1 non-specific dizziness). None of the patients were experiencing attacks of vertigo within a week of EVestG
testing. Ten normal control subjects with no history or symptoms of ear disease were also tested. EVestG was
performed in a separate engineering research facility by investigators who were unaware of their clinical diagnosis.
If EVestG suggested that the probability of Meniere? s disease was 0.5 or greater Meniere? s disease was considered
present by the objective testing. The objective and clinical diagnoses were compared.
Results: EVestG testing correctly identified three of four Meniere ? s disease patients and rejected the diagnosis in
9 of the 10 controls. Two of the 5 dizzy, non-Meniere ? s patients were incorrectly identified as Meniere ? s disease.
The sensitivity and specificity of EvestG testing were 75% and 80%, respectively. EVestG results were statistically
significantly different for Meniere? s patients versus the other dizzy patients and controls (Univariate ANOVA
difference contrasts p = 0.0340) even in this small sample.
Conclusion: The EVestG protocol appeared to show promise as an objective, diagnostic test for Meniere? s disease,
but our sample size is too small to generalize widely.
Level of evidence: N.A. Prospective Human clinical trial.
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Figure 1 Flow chart for recruitment of dizzy patients for the
study. In addition to the dizzy patients 10 normal controls were tested.
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Meniere's disease is an inner ear disorder that can cause
episodes of vertigo, ringing in the ears (tinnitus), a feel-
ing of fullness or pressure in the ear, and fluctuating
hearing loss affecting 0.2% of the population of the
United States [1]. Although the symptoms can be signifi-
cantly disruptive the specific electrophysiological firing
patterns that characterize the disorder are unknown.
We hypothesize that a neurotologic disorder that causes
marked symptoms has some underlying neural firing pat-
terns that are unique to and diagnostic of that disorder.
Currently the clinical diagnosis of Meniere? s disease is
based on the clinical history often using the criteria estab-
lished by the American Academy of Otolaryngology-Head
and Neck Surgery (AAO-HNS) [2]. Unfortunately clinical
descriptions vary across time, examiners and within the
same patient. Definitive histologic confirmation of clinical
diagnosis can only be made post-mortem. There is a need
for objective testing to confirm Meniere? s disease specific-
ally and vestibular problems in general.
A new test of vestibular function called EVestG [3,4] has
been described that utilized sophisticated mathematical
techniques to a vestibular-evoked signal that may be spe-
cific for Meniere? s disease. While many vestibular tests
cause nausea and dizziness or may take prolonged time
these are not issues with EVestG. This test takes about
30 minutes, involves slow, easily tolerated motion. EVestG
is easier for patients to tolerate than any current clinical
vestibular test. The algorithm has been trained with sub-
jects from Alfred Hospital in Melbourne, Australia. Here
we present the blinded application of the result to a new
set of unknown patients from Winnipeg, Canada.
Methods
Two hundred fifty-six consecutive patients, who presented
for electronystagmography (ENG), were asked to partici-
pate in this research study. Ninety-one patients indicated
that they would participate in this project but only 10 ac-
tually consented and completed all testing including
EVestG, and met our other inclusion criteria (previously
undergone audiometric testing and MRI scan). Thus, the
database of this study included those 10 patients. Patients
were not selected on the basis of any particular diagnosis.
Ten age-matched normal controls were also recruited for
comparison selected from staff, students and friends. Con-
trol patients denied dizziness or hearing problems. The
numbers of patients approached for testing and who fi-
nally were tested illustrates the difficulties in subject re-
cruitment in this type of research. In order to determine
whether differences in EVestG results merely reflected
ENG or auditory abnormalities, ENG data consisting of
the sum of the four caloric exams and the unilateral weak-
ness as well as the average speech reception threshold
(SRT) were collected for the patient group.EVestG data for one of the 10 patients had too much
electrical noise to permit analysis; thus, our final dataset
consists of 9 patients including 4 with Meniere? s disease
and 5 with other vestibular disorders (2 vestibular neuritis,
2 benign positional vertigo and 1 ? non-specific? dizziness
(see Figure 1) and 10 controls. Patients and controls were
asymptomatic at the time of testing. All patients were seen
by an experienced, fellowship-trained clinical neurotolo-
gist for treatment of dizziness, who assigned a diagnosis of
either ? Meniere? s disease? using the AAO criteria [2] or
? non-Meniere? s.? ENG and audiometric findings and the
diagnosis were not communicated to the researchers per-
forming EVestG testing in another facility on another day.
The protocols were approved by the Ethics Review Boards
of the University of Manitoba and Riverview Heath Centre
in Winnipeg.
The clinical diagnosis was benign positional vertigo in 2
patients, vestibular neuritis in 2 patients, nonspecific dizzi-
ness in 1 patient and Meniere? s disease in 4 patients. One
Meniere? s patient had crisis of Tumarkin, and had under-
gone gentamicin ablation. One vestibular neuritis patient
met criteria for bilaterally reduced caloric responses, and
Table 1 Classification of subjects using EvestG probability
>0.5 criterion
Meniere? s Non-Meniere? s Totals
EvestG suggests Meniere? s 3 3 6
EvestG does not suggest
Meniere? s
1 12 13
Totals 4 15 19
Classification of subject based on EvestG testing final vote probability of
Meniere? s disease >0.5 for Meniere? s, and Non-Meniere ? s (other dizziness
diagnosis plus Controls). In this sample the sensitivity of the test was 75%
and the specificity was 80%. If controls are excluded the specificity remains
75% but the sensitivity drops to 60%.
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cunar infarcts on MRI scanning.
Definitions of clinical diagnoses
Meniere ? s disease was diagnosed in subjects who met the
AAO-HNS guidelines for diagnosis of Meniere ? s disease
on clinical presentation in patients presenting with epi-
sodic spinning vertigo spells lasting at least 30 minutes
with asymmetric sensorineural hearing loss, not ex-
plained by other pathology, associated with either aural
fullness or roaring tinnitus [2]. ENG and EVestG testing
was performed after the clinical diagnosis was made.
Vestibular neuritis was diagnosed in patients presenting
with a history predominantly of a prolonged spell of spin-
ning vertigo, possibly with nausea and vomiting, but no
hearing loss or other focal neurological signs or symptoms.
Benign positional vertigo was diagnosed in patients
presenting with brief episodes of spinning vertigo pre-
cipitated by changes of the head with respect to gravity,
lasting less than a minute and positive Dix-Hallpike test
marked by symptomatic, paroxysmal, geotrophic, rota-
tory nystagmus, associated latency of onset after assum-
ing the provocative position with no other pathology.
Non-specific dizziness was diagnosed in one patient
who presented with episodic imbalance episodes lasting
hours, occurring erratically, without hearing loss or evi-
dence of other neuro-otological disorder on clinical exam.
EVestG testing
The EVestG technique has been described previously
[5]. Briefly, it consists of modified electocochleography
(ECoG) [4] recording in which the multiple repetitions
of acoustic stimuli of ECoG are replaced by a vestibular
tilt stimulus, performed only once or twice instead of
hundreds of times as for ECoG. Active electrode is
placed inside ear canal and reference electrode on the
ear lobe (as explained in the accompanying paper [5]).
For this study, we considered the ipsilateral, contralateral
(roll) tilt stimuli only; we will present the results of
backward tilt stimulus in a future paper. For each tilt
time, periods of interest were labeled at times of the pos-
itional changes in the tilt as illustrated in Figure two of
the accompanying paper [5].
As explained in the accompanying paper [5], the algo-
rithm was trained using a different dataset than the one in
this study. Based on the outcome of that study, we calcu-
lated the same final characteristic features selected as
those features in the training study; then, using linear dis-
criminant analysis (LDA) [6] (trained by the previous data-
set), we assigned a probability as the feature belonged to a
person either with ? Meniere? s? or ? not Meniere? s? . In other
words, each feature was used in a LDA classifier to vote
for ? Meniere? s? or ? not Meniere? s? . Averaging the probabil-
ities for each feature from the LDA classifiers, resulted ina final ? vote? ; if the average probability was equal or
greater than 50% for the ? Meniere? s? vote, the subject was
then classified as Meniere? s disease.
Statistical analysis
The sensitivity and specificity of EVestG testing as predic-
tors of the clinical diagnosis of Meniere? s disease were de-
termined by comparing the final vote of the classification
results with those of the clinical diagnosis. Using IBM
SPSS v22 (Chicago) Univariate ANOVA was carried out
on the patients to determine whether other vestibular test
results (unilateral weakness, sum of the four caloric tests)
were predictive of the final EVestG-based classification;
this was not run on control subjects as they had no ENG
or audiometric data. Univariate ANOVA was also carried
out on the combined patient and control subjects data to
assess differences in the final EVestG-based classification
among controls, Meniere? s patients and non-Meniere? s pa-
tients. We include information on the ? effect size (η2), to
estimate the amount of variability accounted for by the
model, as well as statistical significance at the level of
p = 0.05. Finally, linear regression analysis was carried out
on the final EVestG-based classification and the mean
SRT to assess the possibility whether the EvestG results
were dependent on hearing.
Results
The EVestG-based diagnostic analysis correctly identi-
fied Meniere? s disease in 3 of 4 Meniere ? s patients (75%
sensitivity) and correctly identified non-Meniere ? s sub-
jects (other dizziness diagnoses and controls) in 12 of 15
patients (80% specificity). The results are summarized in
Table 1. If only patients are included, the sensitivity for
detection of Meniere ? s disease remains 75% but the spe-
cificity (3 out of 5 patients with non-Meniere ? s diagno-
ses) would drop to 60%. The only Meniere? s patient
identified incorrectly was the patient with the crisis of
Tumarkin variant and had undergone intratympanic
gentamicin ablation therapy suggesting that EVestG may
only apply to classical Meniere ? s disease.
Univariate analysis of variance (ANOVA) was conducted
for vestibular tests. The final EVestG-based classification
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lateral weakness score from ENG testing and sum of the
four calorics were three independent variables. The skew
test [7] indicated that the data did not depart significantly
from a normal distribution justifying a parametric test.
Levene? s test of equality of variances indicated that vari-
ances did not differ significantly so adjustment for unequal
variances was not needed. There were no significant differ-
ences for EVestG-based classification for Meniere? s disease
(yes or no) (F = 2.76, p = 0.16, η2 = 0.356), unilateral weak-
ness score (F = 2.66, p = 0.164, η2 = 0.347) or sum of cal-
oric tests (F = 0.153 p = 0.711, η2 = 0.030). Regression
analysis was performed to assess the effect of hearing on
final EVestG-based classification. The relationship be-
tween final EVestG-based classification e and mean SRT
was not significant (r2 = 0.51, p = 0.055).
Discussion
This paper illustrates the great difficulty in recruiting
and testing volunteer patients, who may not be feeling
well for clinical trials such as this. Although EVestG
testing is safe, quick and free of adverse effects, subjects,
particularly subjects who do not feel well, are reluctant
to participate. The selection of subjects who are not
acutely ill probably makes this test more applicable to
the typical clinical situation for vestibular testing, usually
performed when patients are asymptomatic. We started
with 256 patients, which reduced to 9 in the final ana-
lysis. While we are encouraged by these preliminary re-
sults, we must point out that this is a small sample.
The roll stimulus was chosen to highlight unilateral
pathologies. Meniere ? s disease usually (and for all pa-
tients in this series) a unilateral disease so that it is not
surprising that side tilts (roll) were diagnostic. With lar-
ger datasets we may find that the neural patterns that
we identified herein are secondary to some other factors
such as hearing loss, general vestibular hypofunction, or
something else. The goal is to identify neural firing pat-
terns that permit the objective, specific diagnosis of
Meniere ? s disease. We expect that greater understanding
of the pathophysiology would follow, as would more reli-
able, measureable treatments. Nevertheless, we need lar-
ger numbers to validate the diagnostic ability of EVestG.
We realize that many other factors and combinations of
factors need to be assessed and controlled for but this
requires larger numbers of patients to accomplish. Im-
portantly, if the training of the classifier was to include
other dizziness diagnosis improved separation of these
pathologies from Meniere ? s may be seen; this is a current
investigation.
Diagnosis of Meniere ? s disease is currently based on
clinical criteria and the variability and subjectivity of
clinical diagnosis is another source of error. In a larger
dataset we anticipate that the disagreement betweenobjective and subjective diagnoses will decrease as the
standard deviations in each group decrease and the
groups ? data form more defined clusters. Thus, with a
larger dataset we hope to enhance the diagnostic classi-
fier algorithm to become a useful tool to the level that
clinicians will have enough confidence in EVestG to
trust the objective diagnosis over clinical impressions.
Efforts toward this goal are ongoing.
Conclusion
EVestG testing is a sophisticated method of detecting
signal features that may be useful in the objective diag-
nosis of Meniere ? s disease.
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